CA - NervGen Pharma GAAP EPS of -$0.38 April, 17 2024 11:54 AM CA Inc. 2024-04-17 11:54:32 ET NervGen Pharma press release ( OTCQX:NGENF ): FY GAAP EPS of -$0.38. NervGen had cash and investments of $11.7 million as of December 31, 2023, compared to $22.5 million as of December 31, 2022. For further details see: NervGen Pharma GAAP EPS of -$0.38